21
Participants
Start Date
June 30, 2013
Primary Completion Date
June 30, 2015
Study Completion Date
November 30, 2015
Birinapant
"Dose escalation part: (Drug escalation dose levels)~* Dose Level (1) - 13mg/m2 (twice a week for 3 of 4 weeks)~* Dose Level (-1) - 11 mg/m2 (twice a week for 3 of 4 weeks)~* Dose Level (2) - 13mg/m2 (twice weekly x 4 weeks)~* Dose Level (3a) - 17mg/m2 (twice weekly × 4 weeks)OR~* Dose Level (3b) - 17mg/m2 (twice a week for 3 of 4 weeks)"
5-Azacitidine
Dose Level (0) - 75mg/m2 daily
Roswell Park Cancer Institute, Buffalo
University of Pennsylvania, Abramson Cancer Center, Philadelphia
Mayo Clinic Jacksonville, Jacksonville
The University of Texas M.D. Anderson Cancer Center, Houston
Mayo Clinic Scottsdale, Scottsdale
Palo Verde Hematology Oncology, Glendale
California Cancer Associates for Research and Excellence, Fresno
Lead Sponsor
TetraLogic Pharmaceuticals
INDUSTRY